-
Phosbind Acrylamide: A Mechanism-Led Assay Strategy
2026-10-01
Phosbind Acrylamide enables antibody-independent protein phosphorylation analysis through mobility shifts in SDS-PAGE. This guide adds a mechanism-led framework inspired by MCM8-9-HROB research to connect phosphorylation state with biochemical function.
-
PXR Activation, Liver Regeneration, and CYP Activity
2026-09-30
This rat study shows that pregnane X receptor activation can couple liver enlargement and regeneration with increased metabolic activity of CYP3A1/2 and CYP2C6/11. By combining partial hepatectomy, a CYP probe-drug cocktail, plasma pharmacokinetics, and hepatic protein measurements, the work distinguishes liver growth from functional restoration and clarifies how PXR reshapes drug metabolism during regeneration.
-
Oseltamivir acid: Applied Research Workflows
2026-09-29
Oseltamivir acid supports a two-track research strategy: direct influenza neuraminidase inhibition and exploratory sialidase-linked oncology studies. This guide converts its mechanism, solubility profile, resistance considerations, and translational limitations into practical assay workflows.
-
iMSC Exosomes Reprogram Macrophages in Disc Degeneration
2026-09-29
This reference study identifies a reciprocal inflammatory circuit between senescent nucleus pulposus cells and macrophages in intervertebral disc degeneration. It shows that exosomes from human iPSC-derived mesenchymal stem cells deliver miR-100-5p, suppress mTORC1-associated signaling, reprogram macrophage metabolism, and reduce degeneration in a rat model.
-
LY2109761: Smad2/3 Assay Workflows
2026-09-28
Learn how to use LY2109761 as a TGF-β receptor type I and II dual inhibitor for pathway validation, cancer-cell assays, radiation studies, and fibrosis-oriented experiments. The workflow emphasizes fresh DMSO handling, orthogonal controls, quantitative Smad2/3 readouts, and practical troubleshooting.
-
Acridine Orange hydrochloride: Practical Workflow Guide
2026-09-28
Acridine Orange hydrochloride provides differential fluorescence for nucleic-acid staining, supporting cell cycle analysis and flow-based assessment of DNA and RNA. Use it when nucleic-acid-associated fluorescence is the readout; it is not, by itself, a specific apoptosis test or a substitute for validated orthogonal assays.
-
SP1–ADAM10–DRP1 Axis in Hypoxic Pulmonary Hypertension
2026-09-27
This study links SP1-dependent ADAM10 expression in hypoxic endothelial cells to changes in neighboring smooth muscle cells, identifying DRP1 and PI3K/AKT/mTOR signaling as candidate mediators of pulmonary vascular remodeling. Its conditioned-medium experiments and pharmacological perturbations provide a framework for testing endothelial-to-smooth-muscle communication, while leaving the identity of the active ADAM10-associated signal and the precise role of DRP1 open for further study.
-
NMDAR–Cav2.1 Control of PV Interneuron Maturation
2026-09-26
Singh and colleagues show that NMDARs in developing parvalbumin interneurons are required for maturation of evoked GABA release, with evidence implicating recruitment of Cav2.1 channels rather than excitability alone. The findings connect developmental receptor function to cortical inhibitory output and offer a framework for testing how impaired interneuron maturation may affect excitation–inhibition balance.
-
Pam3CSK4 TFA: A Practical TLR1/2 Assay Guide
2026-09-26
Use Pam3CSK4 TFA to isolate TLR1/2-driven responses from broader inflammatory signals, with a practical workflow for cytokine profiling and troubleshooting. A maternal–newborn GBS study shows why pairing controlled ex vivo stimulation with IL-17A measurement can sharpen research questions—without treating an experimental assay as a clinical test.
-
GATA6 Loss Drives Colorectal Cancer Metastasis
2026-09-25
Serial transplantation of colorectal cancer organoids and integrated RNA-seq/ATAC-seq analyses identify GATA6 loss as a regulator of metastatic lineage plasticity. The study links this loss to fetal-like and basal-like/squamous programs, LGR5-positive cell generation, and increased liver metastasis, with comparatively little effect on primary tumor growth.
-
A40926: Dalbavancin Precursor and Research Guide
2026-09-25
A40926 is a natural glycopeptide antibiotic and the dalbavancin precursor used in research on Gram-positive pathogens and bacterial cell wall synthesis. Published work links its biosynthesis to pathway-specific regulators, while product information reports pathogen-specific MIC values and assay ranges that require interpretation in their stated experimental context.
-
Pazopanib and ATRX-Aware Translational Research
2026-09-24
Pazopanib (GW-786034) can help researchers interrogate angiogenic and tumor-cell signaling, but its broad kinase profile calls for careful experimental design. We connect RTK biology with ATRX-aware glioma research, distinguish class-level evidence from compound-specific hypotheses, and outline a practical path from target engagement to translational interpretation.
-
QNZ (EVP4593): From Pathway Potency to Translation
2026-09-24
QNZ (EVP4593) offers a potent experimental handle on NF-κB pathway activity. This article considers how to use its reported cellular and preclinical findings to design stronger, context-aware translational studies—while distinguishing pathway modulation from proof of therapeutic efficacy.
-
DiscoveryProbe Protease Inhibitor Library Workflow
2026-09-23
Build phenotype-first and target-focused screens with an automation-ready collection of 825 protease inhibitors. The workflow combines protease inhibition, cell-based phenotyping, and orthogonal validation to distinguish actionable biology from nonspecific toxicity or assay interference.
-
PBS (Phosphate-Buffered Saline) Lab Guide
2026-09-22
PBS (Phosphate-Buffered Saline), SKU K2818, is a sterile, ready-to-use isotonic buffer for cell washing, reagent dilution, and selected in vitro workflows requiring controlled pH and osmolarity. It should not replace culture medium or assay-specific buffers without compatibility testing and is intended for scientific research only, not diagnostic, clinical, or medical use.